Autopsy report · NCT01728961
Pharmacology of Antimalarial Therapy With or Without Antiretroviral Therapy
Cause of deathSlow enrollment, also funding or business
“Slow accrual and funding limitations.”
Life of this trial
- Registered 7 months after it had already started.
- Ran for about 2 years 1 month before it stopped.
- 19 participants planned (an estimate, not an actual count).
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- International Maternal Pediatric Adolescent AIDS Clinical Trials Group
- Sponsor type
- University, hospital or other
- Conditions
- HIV Infection; Malaria
- Interventions
- Artemether/Lumefantrine (AL)
- Participants
- 19 (planned, not actual)
- Sites
- 3
- Countries
- Malawi, Uganda
Trials that died the same way
- Prehabilitation With Aerobic and Resistance Exercise for Improving Physical Fitness and Quality of Life Outcomes in Older Patients Undergoing CAR-T Therapy for Relapsed or Refractory Multiple Myeloma
“Limited funding, slow accrual” - Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma
“Slow accrual and lack of funding” - Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease
“Lack of funding and slow accrual” - Treating Breast Cancer Patients Undergoing Trastuzumab Treatment With Carvedilol to Reduce Incidence of Heart Failure
“slow accrual; insufficient funding to continue to accrue” - Adolescent Daughters' Response and Adjustment to Maternal Breast Cancer
“due to slow accrual and lack of funding”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.